Hospira
Hospira Recalls Naloxone Hydrochloride Injection
Hospira issued a voluntary recall of one of its naloxone products because of it might contain loose particulate ...
JUNE 5, 2018
First Epoetin alfa Biosimilar Receives FDA Approval for Anemia
Retacrit is the first U.S. biosimilar erythropoiesis-stimulating agent (ESA). Although not listed as an ...
MAY 15, 2018
FDA Approves Inflectra, Biosimilar to Remicade
Inflectra is the second U.S. biosimilar approved and the first monoclonal antibody.
APRIL 6, 2016
Load more